Package 60219-1145-3

{"route": ["ORAL"], "spl_id": "7fb8acac-13ca-47ca-8b06-d12900d4943b", "openfda": {"nui": ["N0000000246", "N0000175889", "N0000190114", "N0000182137"], "upc": ["0360219114463", "0360219114531"], "unii": ["YO603Y8113"], "rxcui": ["670026", "1359269"], "spl_set_id": ["92b286d5-1ee5-435b-9e1d-2e95c7f2ec69"], "pharm_class_epc": ["Protease Inhibitor [EPC]"], "pharm_class_moa": ["HIV Protease Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (60219-1145-3)  / 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC", "package_ndc": "60219-1145-3", "marketing_start_date": "20231209"}], "brand_name": "Darunavir", "product_id": "60219-1145_7fb8acac-13ca-47ca-8b06-d12900d4943b", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "Protease Inhibitor [EPC]"], "product_ndc": "60219-1145", "generic_name": "Darunavir", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Darunavir", "active_ingredients": [{"name": "DARUNAVIR", "strength": "800 mg/1"}], "application_number": "ANDA212493", "marketing_category": "ANDA", "marketing_start_date": "20231209", "listing_expiration_date": "20261231"}